HBW
GILD icon

Hazlett, Burt & Watson’s Gilead Sciences GILD Stock Holding History

Hazlett, Burt & Watson’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$374K Buy
2,958
+22
+0.7% +$2.9K 0.1% 181
2026
Q1 		$408K Sell
2,936
-249
-8% -$34.9K 0.13% 167
2025
Q4 		$392K Buy
3,185
+285
+10% +$34.6K 0.13% 157
2025
Q3 		$322K Sell
2,900
-75
-3% -$8.53K 0.11% 166
2025
Q2 		$330K Buy
2,975
+50
+2% +$5.32K 0.14% 145
2025
Q1 		$327K Buy
2,925
+25
+0.9% +$2.58K 0.15% 139
2024
Q4 		$269K Hold
2,900
– – 0.12% 164
2024
Q3 		$243K Hold
2,900
– – 0.11% 178
2024
Q2 		$199K Hold
2,900
– – 0.1% 182
2024
Q1 		$213K Hold
2,900
– – 0.13% 164
2023
Q4 		$234K Hold
2,900
– – 0.16% 136
2023
Q3 		$217K Buy
2,900
+35
+1% +$2.69K 0.16% 137
2023
Q2 		$220K Buy
2,865
+10
+0.4% +$798 0.16% 129
2023
Q1 		$237K Buy
2,855
+5
+0.2% +$414 0.19% 111
2022
Q4 		$245K Sell
2,850
-200
-7% -$15.8K 0.22% 103
2022
Q3 		$188K Hold
3,050
– – 0.18% 116
2022
Q2 		$188K Hold
3,050
– – 0.17% 121
2022
Q1 		$181K Buy
+3,050
New +$195K 0.14% 147

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Hazlett, Burt & Watson's GILD Position: Q2 2026 in Review

Hazlett, Burt & Watson increased its Gilead Sciences (GILD) stake by 0.75% in Q2 2026, buying an estimated $2.9K and bringing the position to 2,958 shares worth $374K. The position accounts for 0.1% of the portfolio, ranked #181.

Hazlett, Burt & Watson first reported a position in GILD in Q1 2022 and has held it in 18 quarters since. The position peaked at $408K in Q1 2026. 2,283 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Hazlett, Burt & Watson held 2,958 shares of Gilead Sciences worth $374K as of Q2 2026.
  • Hazlett, Burt & Watson bought 22 Gilead Sciences shares in Q2 2026, an estimated $2.9K.
  • Gilead Sciences made up 0.1% of Hazlett, Burt & Watson's portfolio in Q2 2026, its #181 holding.
  • Hazlett, Burt & Watson first reported a position in Gilead Sciences in Q1 2022 and has held it in 18 quarters since.
  • Hazlett, Burt & Watson's Gilead Sciences position peaked at $408K in Q1 2026.
  • 2,283 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Hazlett, Burt & Watson's 13F filing for Q2 2026, filed 30 Jul 2026.